Anti-tumor necrotic factor antibody for treatment of neuro-Behçet's disease, a case report

Clinical Neurology and Neurosurgery

Volumn 110, Issue 3, 2008, Pages 315-316

  Borhani Haghighi, A ^a   Safari, A ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Beh et's syndrome; Infliximab; Neuro Beh et's disease

Indexed keywords

ACETYLSALICYLIC ACID; COLCHICINE; CYCLOPHOSPHAMIDE; INFLIXIMAB; METHYLPREDNISOLONE; PREDNISOLONE; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; BEHCET DISEASE; CASE REPORT; CONFUSION; FACIAL NERVE PARALYSIS; HEADACHE; HUMAN; LETTER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; QUADRIPLEGIA; SKIN ULCER; WEAKNESS;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; BEHCET SYNDROME; BRAIN; HUMANS; IMMUNOTHERAPY; MAGNETIC RESONANCE IMAGING; MALE; METHYLPREDNISOLONE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 39749169197     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2007.10.005     Document Type: Letter

References (5)

1. Licata G., Pinto A., Tuttolomondo A., Banco A., Ciccia F., Ferrante A., et al. Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behcet's syndrome. Ann Rheum Dis 62 3 (2003) 280-281
2. Sarwar H., McGrath Jr. H., and Espinoza L.R. Successful treatment of long-standing neuro-Behcet's disease with infliximab. J Rheumatol 32 (2005) 181-183
3. Ribi C., Sztajzel R., Delavelle J., and Chizzolini C. Efficacy of TNF-alpha blockade in cyclophosphamide resistant neuro-Behcet disease. J Neurol Neurosurg Psychiatry 76 12 (2005) 1733-1735
4. Alty J.E., Monaghan T.M., and Bamford J.M. A patient with neuro-Behcet's disease is successfully treated with etanercept: further evidence for the value of TNFalpha blockade. Clin Neurol Neurosurg 109 3 (2007) 279-281
5. Siva A., Kantarcy O., Saip S., Hamuryudan V., Altyntas A., and Yazici H. Neuro-Behcet syndrome: prognostic factors and survival. J Neurol 245 (1998) 362